Prophylaxis of complications after radical operations in patients, suffering a mammary gland cancer
Objective. Elaboration of prophylactic measures for complications after radical operations in patients, suffering mammary gland cancer, and estimation of its efficacy.
Materials and methods. Immediate results of surgical treatment were analyzed in 147 patients, suffering mammary gland cancer, and distributed, depending on perioperative treatment methods, into: the1st (comparison group) - 92 women-patients, to whom a standard treatment was applied, the second one (main group) - 55 women-patients, in whom complex of prophylactic measures was applied, including organizational, as well as compressive and medicinal therapy.
Results. Application of complex of prophylactic measures was accompanied by reduction of the development rate of postoperative oedema from 50% (comparison group) to 25% (p=0.003), the seroma’s formation - from 29 to 11% (p=0.010), development and severity of postmastectomy syndrome, lymphorrhea - from 29 to 18% (p=0,131) and the wounds complications - from 25 to 7.3% (p=0.007).
Conclusion. After radical operations with the lymph node dissection in patients, suffering mammary gland cancer, the early morbidity rate is rather high, and mainly connected with lymphovenous drainage outflow. The complex of measures, aiming at minimization of the patients’ stationary stay, early extraction of draining tubes, early activation of the patients, the improved compressive and medicinal therapy permits to reduce the rate and severity of morbidity and to accelerate the patients’ recovery and reconvalescence.
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1459-544. doi: 10.1016/S0140-6736(16)31012-1.
Fedorenko ZP, Gulak LO, Mikhaylovich YUY, Gorokh el, Ryzhov AYu, Sumkina OV Kutsenko LB. Rak v Ukraine, 2016 - 2017. Zabolevayemost, smertnost, pokazateli deyatelnosti onkologicheskoy sluzhby. In: Kolesnik OO editor. Byulleten natsionalnogo kantser-reyestra Ukrainy. 2018 (19). Available from: http://www.ncru.inf.ua/publications/BULL_19/index.htm. [In Ukrainian].
Senkus E. Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015; 26 Suppl 5: v8-30, 2015. doi:10.1093/annonc/mdv298.
Dayan JH, Ly CL, Kataru RP, Mehrara BJ. Lymphedema: Pathogenesis and Novel Therapies. Annu Rev Med. 2018; 69:263-76. doi: 10.1146/annurev-med-060116-022900.
Nguyen TT, Hoskin TL, Habermann EB, Cheville AL, Boughey JC. Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study. Ann Surg Oncol. 2017; 24(10):2972-80. doi: 10.1245/s10434-017-5960-x.
Abass MO, Gismalla MDA, Alsheikh AA, Elhassan MMA. Axillary lymph node dissection for breast cancer: efficacy and complication in developing countries. J Glob Oncol. 2018; 4:1-8. doi: 10.1200/JGO.18.00080.
Madsen RJ, Esmonde NO, Ramsey KL, Hansen JE. Axillary lymph node dissection is a risk factor for major complications after immediate breast reconstruction. Ann Plast Surg. 2016;77(5):513-6. doi: 10.1097/SAP.0000000000000653.
Marinescu SA, Bejinariu CG, Şapte E, Marinaş MC, Giuglea C. Complications related to breast reconstruction after mastectomy using multiple surgical techniques - a national and international comparative analysis. Rom J Morphol Embryol. 2019;60(1):87-93. PMID: 31263831.
Gallagher M, Jones DJ, Bell-Syer SV. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database Syst Rev. 2019;9:CD005360. doi: 10.1002/14651858.CD005360.pub5.
Sayegh HE, Asdourian MS, Swaroop MN, Brunelle CL, Skolny MN, Salama L, Taghian AG. Diagnostic methods, risk factors, prevention, and management of breast cancer-related lymphedema: past, present, and future directions. Curr Breast Cancer Rep. 2017;9(2):111-21. doi: 10.1007/s12609-017-0237-8.
/ Josephine DSP. Evaluation of Lymphedema Prevention Protocol on Quality of Life among Breast Cancer Patients with Mastectomy. Asian Pac J Cancer Prev. 2019;20(10):3077-84. doi: 10.31557/APJCP.2019.20.10.3077.
Chiappa C, Fachinetti A, Boeri C, Arlant V, Rausei S, Dionigi G, Rovera F. Wound healing and postsurgical complications in breast cancer surgery: a comparison between PEAK PlasmaBlade and conventional electrosurgery - a preliminary report of a case series. Ann Surg Treat Res. 2018;95(3):129-134. doi: 10.4174/astr.2018.95.3.129.
Gambardella C, Clarizia G, Patrone R, Offi C, Mauriello C, Romano R et al. Advanced hemostasis in axillary lymph node dissection for locally advanced breast cancer: new technology devices compared in the prevention of seroma formation. BMC Surg. 2019;18(Suppl 1):125. doi: 10.1186/s12893-018-0454-8.
Isozaki H, Yamamoto Y, Murakami S, Matsumoto S, Takama T. Impact of the surgical modality for axillary lymph node dissection on postoperative drainage and seroma formation after total mastectomy. Patient Saf Surg. 2019;13:20. doi: 10.1186/s13037-019-0199-z.
Thomson DR, Sadideen H, Furniss D. Wound drainage after axillary dissection for carcinoma of the breast. Cochrane Database Syst Rev. 2013;(10):CD006823. doi: 10.1002/14651858.CD006823.pub2
This work is licensed under a Creative Commons Attribution 4.0 International License.